β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice

Diabetologia

Volumn 57, Issue 3, 2014, Pages 532-541

  Ravier, Magalie A ^a,b   Leduc, Michele ^a,b   Richard, Joy ^a,b   Linck, Nathalie ^a,b   Varrault, Annie ^a,b   Pirot, Nelly ^c,d   Roussel, Morgane M ^a,b   Bockaert, Joël ^a,b   Dalle, Stéphane ^a,b   Bertrand, Gyslaine ^a,b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

^c CENTRE VAL D AURELLE   (France)

^d INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Arrestin; GLP 1; High fat diet; Insulin secretion; Pancreatic beta cell mass; Pancreatic islet biology

Indexed keywords

BETA ARRESTIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; INSULIN RECEPTOR; RETINA S ANTIGEN;

ANIMAL; EXPERIMENTAL DIABETES MELLITUS; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; MOUSE; PANCREAS; PANCREAS ISLET BETA CELL; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ARRESTINS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; GLUCAGON-LIKE PEPTIDE 1; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; PANCREAS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 84894545046     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3130-7     Document Type: Article

References (50)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
2. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
3. Weir GC, Bonner-Weir S (2013) Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann NY Acad Sci 1281:92-105
4. Ahren B (2009) Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369-385
5. Goldfine AB, Kulkarni RN (2012) Modulation of beta-cell function: a translational journey from the bench to the bedside. Diabetes Obes Metab 14(Suppl 3):152-160
6. Gilon P, Henquin JC (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22:565-604
7. Thorens B (2011) Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab 13(Suppl 1):82-88
8. Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17:819-837
9. Gautam D, Han SJ, Duttaroy A et al (2007) Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes Obes Metab 9(Suppl 2):158-169
10. Leibiger IB, Leibiger B, Berggren PO (2008) Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 28:233-251
11. Assmann A, Hinault C, Kulkarni RN (2009) Growth factor control of pancreatic islet regeneration and function. Pediatr Diabetes 10:14-32
12. Braun M, Ramracheya R, Rorsman P (2012) Autocrine regulation of insulin secretion. Diabetes Obes Metab 14(Suppl 3):143-151
13. Elghazi L, Bernal-Mizrachi E (2009) Akt and PTEN: beta-cell mass and pancreas plasticity. Trends Endocrinol Metab 20:243-251
14. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ (2009) Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 17:443-458
15. Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308:512-517
16. Luttrell LM, Gesty-Palmer D (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305-330
17. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510
18. Whalen EJ, Rajagopal S, Lefkowitz RJ (2011) Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med 17:126-139
19. DeFea KA (2011) Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal 23:621-629
20. Hupfeld CJ, Olefsky JM (2007) Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins. Annu Rev Physiol 69:561-577
21. Luan B, Zhao J, Wu H et al (2009) Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457:1146-1149
22. Quoyer J, Longuet C, Broca C et al (2010) GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J Biol Chem 285:1989-2002
23. Sonoda N, Imamura T, Yoshizaki T, Babendure JL, Lu JC, Olefsky JM (2008) Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci U S A 105:6614-6619
24. Talbot J, Joly E, Prentki M, Buteau J (2012) beta-Arrestin1 mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic beta INS832/13 cells. Mol Cell Endocrinol 354:65-70
25. Broca C, Quoyer J, Costes S et al (2009) beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells. J Biol Chem 284:4332-4342
26. Kong KC, Butcher AJ, McWilliams P et al (2010) M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. Proc Natl Acad Sci U S A 107:21181-21186
27. Dalle S, Ravier MA, Bertrand G (2011) Emerging roles for beta-arrestin-1 in the control of the pancreatic beta-cell function and mass: new therapeutic strategies and consequences for drug screening. Cell Signal 23:522-528
28. Zhang M, Zhu Y, Mu K et al (2013) Loss of beta-arrestin2 mediates pancreatic-islet dysfunction in mice. Biochem Biophys Res Commun 435:345-349
29. Bertrand G, Ishiyama N, Nenquin M, Ravier MA, Henquin JC (2002) The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related. J Biol Chem 277:32883-32891
30. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
31. Sachdeva MM, Stoffers DA (2009) Minireview: meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. Mol Endocrinol 23:747-758
32. Syme CA, Zhang L, Bisello A (2006) Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor. Mol Endocrinol 20:3400-3411
33. Jorgensen R, Martini L, Schwartz TW, Elling CE (2005) Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype. Mol Endocrinol 19:812-823
34. Jorgensen R, Kubale V, Vrecl M, Schwartz TW, Elling CE (2007) Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). J Pharmacol Exp Ther 322:148-154
35. Schelshorn D, Joly F, Mutel S, Hampe C, Breton B, Mutel V, Lutjens R (2012) Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation. Mol Pharmacol 81:309-318
36. Alejandro EU, Lim GE, Mehran AE et al (2011) Pancreatic beta-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription. FASEB J 25:3884-3895
37. Gu C, Stein GH, Pan N et al (2010) Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab 11:298-310
38. Meur G, Qian Q, da Silva XG et al (2011) Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6). J Biol Chem 286:13647-13656
39. Lee YC, Nielsen JH (2009) Regulation of beta cell replication. Mol Cell Endocrinol 297:18-27
40. Gunasekaran U, Hudgens CW, Wright BT, Maulis MF, Gannon M (2012) Differential regulation of embryonic and adult beta cell replication. Cell Cycle 11:2431-2442
41. Thorens B (2013) The required beta cell research for improving treatment of type 2 diabetes. J Intern Med 274:203-214
42. Imai J, Katagiri H, Yamada T et al (2008) Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 322:1250-1254
43. El Ouaamari A, Kawamori D, Dirice E et al (2013) Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep 3:401-410
44. Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153:747-758
45. Buzzi F, Xu L, Zuellig RA et al (2010) Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Mol Cell Biol 30:601-612
46. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101
47. Kitamura T, Nakae J, Kitamura Y et al (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110:1839-1847
48. Liu Y, Tanabe K, Baronnier D, Patel S, Woodgett J, Cras-Meneur C, Permutt MA (2010) Conditional ablation of Gsk-3beta in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice. Diabetologia 53:2600-2610
49. Liu Z, Tanabe K, Bernal-Mizrachi E, Permutt MA (2008) Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferation. Diabetologia 51:623-631
50. Zurita E, Chagoyen M, Cantero M et al (2011) Genetic polymorphisms among C57BL/6 mouse inbred strains. Transgenic Res 20:481-489